A.R.T. Advisors’s Tonix Pharmaceuticals TNXP Stock Holding History

A.R.T. Advisors’s Portfolio TNXP Stock Details TNXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Hold	0	–	-$10K	–	251
2020 Q2	–	Hold	0	–	–	–	275
2019 Q3	–	Hold	0	–	-$42K	–	1736
2019 Q2	–	Hold	0	–	–	–	1258
2018 Q4	–	Hold	0	–	-$29K	–	1643
2018 Q3	–	Hold	0	–	–	–	1336
2017 Q4	–	Hold	0	–	-$191K	–	1674
2017 Q3	–	Hold	0	–	–	–	1146
2017 Q2	–	Hold	0	–	–	–	1193
2016 Q2	–	Hold	0	–	-$117K	–	1634
2016 Q1	–	Hold	0	–	–	–	1239
2015 Q4	–	Hold	0	–	-$263K	–	1716
2015 Q3	–	Hold	0	–	–	–	1080
2015 Q2	–	Hold	0	–	–	–	1232
2015 Q1	–	Hold	0	–	–	–	1213
2014 Q4	–	Hold	0	–	–	–	1238

Other funds holding TNXP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Millennium Management

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return